28. 全身性アミロイドーシス Systemic amyloidosis Clinical trials / Disease details


臨床試験数 : 261 薬物数 : 276 - (DrugBank : 81) / 標的遺伝子数 : 68 - 標的パスウェイ数 : 178

  
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT05184088
(ClinicalTrials.gov)
April 20226/1/2022Efficacy of [18F]Florbetaben PET for Diagnosis of Cardiac AL AmyloidosisAn Open-label, Multi-center, Non-randomized Pivotal Phase 3 Study to Evaluate the Efficacy and Safety of [18F]Florbetaben Positron Emission Tomography (PET) Imaging to Diagnose Cardiac AL AmyloidosisCardiac Amyloidosis;AL Amyloidosis;ATTR AmyloidosisDrug: [18F]florbetabenLife Molecular Imaging GmbHNULLNot yet recruiting18 YearsN/AAll200Phase 3NULL
2NCT04392960
(ClinicalTrials.gov)
July 22, 202027/2/2020Novel Imaging Tools in Newly-diagnosed Patients With Cardiac AL AmyloidosisMolecular, Magnetic Resonance, and Echocardiographic Imaging Combined With Biomarkers of Cardiac and Clonal Disease to Predict Survival and Assess Response to Therapy in Cardiac AL AmyloidosisAL AmyloidosisDrug: [18F]FlorbetabenIRCCS Policlinico S. MatteoNULLRecruiting18 YearsN/AAll69N/AItaly